Atea Pharmaceuticals, Inc. (AVIR) Stock buybacks 2024–2025
Atea Pharmaceuticals, Inc. (AVIR) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$25.5MFY2025 · since FY2024: $0 → $25.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $25.5M | — |
| FY2024 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AVIR financial trends
AVIR RevenueAVIR Net incomeAVIR Net marginAVIR Gross profitAVIR Gross marginAVIR Operating incomeAVIR Operating marginAVIR Operating cash flowAVIR Free cash flowAVIR Capital expendituresAVIR Return on equityAVIR Dividends paidAVIR Total assetsAVIR Total liabilitiesAVIR Shareholders’ equityAVIR overview →